Pam Belluck
Posts
Do Vaccines Protect Against Long Covid?
Maybe, according to a growing number of studies, but there’s not yet a definitive answer.
Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials
Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.
Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug
The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and uncertain evidence that it helps patients.
New ALS Treatment, AMX0035, Lacks Evidence of Benefit, FDA Panel Finds
With a 6-4 vote, the group of independent advisers to the agency narrowly concluded that results from another clinical trial are needed to assess whether...
F.D.A. Grants the First Condom Approval for Anal Sex
Though public health experts have long advised the use of condoms for anal sex to protect against H.I.V. and other infections, regulators did not have...
Medicare Proposes to Cover Aduhelm Only for Patients in Clinical Trials
If the preliminary decision is finalized this spring, it would sharply limit the number of patients who use the expensive drug.
Alzheimer's Drug Aduhelm Faces Crucial Medicare Decision
Medicare officials are trying to determine whether to cover Aduhelm, which the F.D.A. approved despite unclear evidence that it helps patients.
Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles
A group of Alzheimer’s experts and health advocates called on the F.D.A. to withdraw its approval of the drug, the latest of several setbacks for...
F.D.A. Will Permanently Allow Abortion Pills by Mail
The decision will broaden access to medication abortion, an increasingly common method, but many conservative states are already mobilizing against it.
Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many...